Brief: Avalon Globocare Corp Announces FDA Registration Renewal For Ketoair
Jan 20 (Reuters) - Avalon Globocare Corp ALBT.O: AVALON GLOBOCARE CORP - ANNOUNCES FDA REGISTRATION RENEWAL FOR KETOAIR - SEC FILING AVALON GLOBOCARE CORP - RENEWAL OF FDA ESTABLISHMENT REGISTRATION FOR THE KETOAIR DEVICE BY QI DIAGNOSTICS LIMITED Source text: [ID:n0001213900-26-005682] Further company coverage: ALBT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Change Agents
See all newsBrief: Change Agents Corporation - Meng Li Resigns As Interim CEO, COO, And Secretary Effective October 8, 2026
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 09:30 PM